Cardiovascular

Latest News

FDA headquarters | Image Credit: Grandbrothers - stock.adobe.com
FDA Approves Acoramidis for ATTR-CM

November 25th 2024

With approval, acoramaidis (Attruby; BridgeBio Pharma) becomes the first agent with a label specifying near-complete stabilization of transthyretin (TTR).

Cardiovascular health | Image Credit: BillionPhotos.com - stock.adobe.com
Unfavorable Health-Related Social Needs Associated With Lower Cardiovascular Health Scores

November 25th 2024

Heart examination | Image credit: Ngampol - stock.adobe.com
Elevated Stress Hyperglycemia Ratio Linked to Higher All-Cause Mortality After Cardiovascular Events

November 20th 2024

Smoking health risk | Image credit: sorapop - stock.adobe.com
How Smoking Cessation Affects Cardiovascular Disease Risk Over Time

November 15th 2024

Stressed female employee | Image Credit: Charlie's - stock.adobe.com
Work-Related Stress Linked to Poor Cardiovascular Health

November 6th 2024

Advancements in Population Health Strategies for Cardiovascular Risk Management

Experts discuss how lipoproteins drive atherosclerotic heart disease, review the different guidelines and recommendations on Lp(a) testing, and insights from clinical trials.

Hands holding a heart with a heartbeat on it and the words AJMC Insights
Continuing Medical Education
View All
December 3rd 2024

Evidence-Based Guidelines Point to Leap in Care for Hypertrophic Cardiomyopathy

December 11, 2024 | 1:00 PM & 8:00 PM ET
December 3rd 2024

Advances and Best Practices for Managed Care Pharmacists in the Treatment of Heart Failure with Preserved Ejection Fraction

1.0 Credits / Cardiology
December 3rd 2024

Exploring Transthyretin-Mediated Amyloidosis and Its Phenotypes: A Comprehensive Approach to Patient Treatment

1.5 Credits / Cardiology, Neurology, Rare Diseases
December 3rd 2024

The Economics of Transthyretin-Mediated Amyloidosis: Balancing Equity and Access in Resource Allocation

1 Credit / Cardiology, Neurology

More News

Variables Involved When Adding Medications to Treat Diabetes
May 27th 2016

Variables Involved When Adding Medications to Treat Diabetes

How Does the Potential for Weight Gain Influence Choice of Therapies?
May 27th 2016

How Does the Potential for Weight Gain Influence Choice of Therapies?

Comparison of Guidelines From ADA and AACE
May 27th 2016

Comparison of Guidelines From ADA and AACE

Complications of Diabetes and Role of Insulin Resistance in Metabolic Syndrome
May 27th 2016

Complications of Diabetes and Role of Insulin Resistance in Metabolic Syndrome

"It Takes a Village" to Tackle the Diabetes Epidemic
May 26th 2016

"It Takes a Village" to Tackle the Diabetes Epidemic

What Is the Role of the Provider in Guiding People to Better Adherence?
May 26th 2016

What Is the Role of the Provider in Guiding People to Better Adherence?

Using Apps to Help Patients Manage Diabetes
May 26th 2016

Using Apps to Help Patients Manage Diabetes

How Can We Align Financing Incentives With Quality?
May 26th 2016

How Can We Align Financing Incentives With Quality?

Why Recent Clinical Trials Make This a "Very Exciting Time" in Diabetes Care
May 26th 2016

Why Recent Clinical Trials Make This a "Very Exciting Time" in Diabetes Care

Using Guidelines to Overcome Clinical Inertia
May 26th 2016

Using Guidelines to Overcome Clinical Inertia

The Pharmacist as a Member of the Managed Care Team
May 26th 2016

The Pharmacist as a Member of the Managed Care Team

Navigating the Evidence: From Clinical Trial to Clinical Practice
May 26th 2016

Navigating the Evidence: From Clinical Trial to Clinical Practice

Engaging the Community to Promote Population Health
May 26th 2016

Engaging the Community to Promote Population Health

The Patient-Centered Medical Home in Diabetes Care
May 26th 2016

The Patient-Centered Medical Home in Diabetes Care

How Do We Evaluate Cardiovascular Risk in Diabetes?
May 26th 2016

How Do We Evaluate Cardiovascular Risk in Diabetes?

Overview of the Diabetes Burden
May 26th 2016

Overview of the Diabetes Burden

Site Logo
May 16th 2016

A Cost-Effectiveness Analysis of Over-the-Counter Statins

Christopher Stomberg, PhD Margaret Albaugh, MA Saul Shiffman, PhD
This paper estimates the costs and benefits of over-the-counter (OTC) statins using data on statin use and cardiovascular risk, clinical studies of statin safety and efficacy, and an OTC statin use trial.
Site Logo
May 9th 2016

Potential of Risk-Based Population Guidelines to Reduce Cardiovascular Risk in a Large Integrated Health System

Galina Inzhakova, MPH Hui Zhou, PhD, MS Macdonald Morris, PhD Megan I. Early, MD, MPH Anny H. Xiang, PhD Steven J. Jacobsen, MD, PhD Stephen F. Derose, MD, MSHS
The authors evaluated the clinical applicability, accuracy, and implications of using an automated risk calculator and risk-based decision tool in an integrated health system.
Site Logo
April 3rd 2016

Data From North Carolina Out-of-Hospital Deaths Raise Many Questions

Mary Caffrey
A small study of sudden out-of-hospital deaths raises questions about the quality of primary care, especially for women.
Site Logo
April 2nd 2016

Population Health Takes Center Stage to Open ACC

Mary Caffrey
Greetings from First Lady Michelle Obama and a lecture from a non-cardiologist on population health set the stage for the 65th Scientific Session of the American College of Cardiology. Prevention is the focus of this year's meeting.
Site Logo
April 2nd 2016

Statins Can Cut Heart Attacks in Moderate-Risk Patients, Study Finds

Mary Caffrey
Results from the HOPE-3 trial, presented on the opening day of the 65th Scientific Session of the American College of Cardiology, suggest cholesterol-lowering statins could have preventive benefits in broader groups of patients than previously thought.
Site Logo
March 21st 2016

Fewer Amputations, Hospital Deaths as Treatment Switches for Patients with Critical Limb Ischemia

Mary Caffrey
The study from researchers at Cleveland Clinic found that during the years before full implementation of the Affordable Care Act, a shift in treatment methods for patients with a painful condition was associated with fewer amputations and deaths. But large disparities remain.
Site Logo
March 14th 2016

Inpatient and 90-Day Postdischarge Outcomes in Cardiac Surgery

Michael Pine, MD, MBA Susan M. Nedza, MD, MBA David G. Locke, BS Agnes M. Reband, BS Gregory Pine, BA
Coronary artery bypass grafting and cardiac valve surgery have dramatically different risk-adjusted outcomes over the 90 days following discharge, and demonstrate the opportunity for care improvement.
Site Logo
January 22nd 2016

High-Cost Patients Split in 3 Camps, Based on Insurance Status

Mary Caffrey
The profile of high-cost patients in a Massachusetts ACO differed greatly, depending on their enrollment in Medicare, Medicaid, or a commercial plan.
Site Logo
January 13th 2016

No Association Found Between DPP-4 Inhibitors and Heart Failure in Review of Claims Data

Mary Caffrey
Last year, an FDA advisory panel called for an updated label for saxagliptin, but the agency is still gathering information.
Site Logo
January 7th 2016

Most Americans Exceed Dietary Recommendations for Salt, CDC Finds

Mary Caffrey
The findings on salt intake were timed to coincide with the release of the 2015 Dietary Guidelines for Americans.
Site Logo
December 4th 2015

CDC: Half of Those Eligible for Cholesterol Drugs Aren't Taking Them

Mary K. Caffrey
The estimate is based on the larger number of Americans now eligible to be treated for high LDL cholesterol, based on guidelines adopted in 2013.
Site Logo
December 3rd 2015

ELIXA Results on Lixisenatide Published in NEJM

Mary K. Caffrey
Results first presented at the American Diabetes Association in June are published. The new drug application has since been filed at FDA.
Site Logo
November 28th 2015

New Drug Application for Lixisenatide Accepted; CV Results Already in Hand

Mary K. Caffrey
Results from the ELIXA trial were presented in June at the 75th Scientific Sessions of the American Diabetes Association.
Site Logo
November 25th 2015

Mississippi to Pay for Bariatric Surgery to Combat Obesity

Mary K. Caffrey
The policy change is aimed at curbing the state's obesity rate as well as comorbidities such as diabetes
<1
...
141516171819202122>

2 Commerce Drive
Suite 100
Cranbury, NJ 08512

© 2024 MJH Life Sciences® and AJMC®.
All rights reserved.

About
Contact
Editorial Boards
Advertise
Do Not Sell My Information
Terms & Conditions
Privacy Policy
AJMC Managed Markets Network Logo
CH LogoCenter for Biosimilars Logo